BRIDGEBIO PHARMA INC (BBIO) Stock Institutional Owners
BRIDGEBIO PHARMA INC (BBIO) is held by 2 institutional investors with a total value of $1.10B. This comprehensive analysis highlights the top institutional holders led by Viking Global Investors, Polen Capital Management, and others, who collectively account for nearly 100% of the total institutional ownership.Viking Global Investors remains the largest institutional holder with a position worth $1.10B. Explore insights into ownership patterns, position sizes, and portfolio allocations to understand institutional investment strategies and market sentiment.
Explore more:
- BRIDGEBIO PHARMA INC (BBIO) stock institutional trading activity
- BRIDGEBIO PHARMA INC (BBIO) stock insider trading activity
- Stock rankings
| Name | Investor/Manager | Portfolio % | Quantity | Reported Balance |
|---|---|---|---|---|
| Viking Global Investors | Ole Andreas Halvorsen | 2.92% | 14,393,934 | $1,100,992,012 |
| Polen Capital Management | David M. Polen | 0.01% | 38,241 | $2,925,054 |
Frequently asked questions about BBIO
Who owns the most BBIO stock?
The largest holders of BBIO are typically major institutional investors such as asset managers and hedge funds reporting on Form 13F. The table above ranks tracked superinvestors by reported position size using the latest available filings for BRIDGEBIO PHARMA INC (BBIO).
Is BBIO widely held by superinvestors?
Many widely followed stocks like BBIO appear across numerous superinvestor portfolios because of liquidity, index inclusion, and fundamentals. The holder count and table above show how broadly BBIO is represented among the institutional managers we track.